Vaishali Pharma P/E Ratio
Current P/E Ratio
23.62
Moderate Valuation
High - Growth expectations or overvalued
Vaishali Pharma (VAISHALI) P/E ratio is 23.62 (Moderate), EPS (TTM) ₹0.31, current price ₹8.03 on NSE — High - Growth expectations or overvalued. Also explore VAISHALI share price charts to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
23.62
Current Price
₹8.03
EPS (TTM)
₹0.31
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.29
Sector Median
31.14
Sector Rank
#11 of 199
Sector Percentile
5.5%
Earnings Breakdown (TTM)
TTM EPS
₹0.34
Mar 2026
₹0.03
Jun 2026
₹0.12
VAISHALI P/E Ratio — Valuation Signal & Historical Context
Vaishali Pharma P/E 23.62 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see VAISHALI screener.
- Trading at discount to sector average PE of 55.29
VAISHALI vs Healthcare Peers — P/E Ratio Comparison
Vaishali Pharma P/E 23.62 vs Healthcare average 55.29, median 31.14 — range 2.86–731.32.
Sector Average
55.29
Sector Median
31.14
Lowest P/E
2.86
Highest P/E
731.32
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.33 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.36 | ₹65 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.25 | ₹6,468 | Low |
| Sunrest Lifescience | SUNREST | 4.32 | ₹69 | Low |
| Dipna Pharmachem | DPL | 5.05 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.15 | ₹70 | Low |
| Shelter Pharma | SHELTER | 5.88 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.99 | ₹34 | Low |
| Royal Sense | ROYAL | 6.22 | ₹47 | Low |